The pathogenetic link between anti-TNF treatment in IBD and iatrogenic secondary psoriasis is still controversial, although it seems unlikely related to common genetic and pathogenic backgrounds (see below, Section 3.4.1) [39]. This evidence concerns the gene TNF and inflammatory bowel disease.